Sarcopenia profoundly impacts the quality of life and longevity in elderly populations. Notably, alterations in thyroid hormone (TH) levels during ageing are intricately linked to the development of sarcopenia. In skeletal muscle, the primary action of TH is mediated through the thyroid hormone receptor alpha (TRα). Emerging evidence suggests that decreased TRα expression may precipitate mitochondrial dysfunction in ageing skeletal muscle tissues. Yet, the precise mechanisms and the potential causative role of TRα deficiency in sarcopenia are not fully understood. This study suggests that TRα may regulate mitochondrial calcium (Ca2+) transport across membranes by targeting the inositol 1,4,5-trisphosphate receptor 1 (IP3R1), as evidenced by ChIP-seq and RNA-seq analyses. Experiments using naturally aged mice, skeletal muscle-specific TRα knockout (SKT) mice, and C2C12 myoblasts were conducted to investigate this process further. Findings include increased IP3R1, mitochondria-associated endoplasmic reticulum membranes (MAM), and mitochondrial Ca2+ in aged skeletal muscle. Additionally, SKT mice exhibited smaller muscle fibres, increased IP3R1 and MAM, and mitochondrial dysfunction. ChIP-qPCR and TRα manipulation in C2C12 cells showed that TRα negatively regulates IP3R1 transcription. Moreover, TRα knockdown cells exhibited increased Ca2+ transfer in MAM and mitochondrial dysfunction, which was ameliorated by the IP3R1 inhibitor 2-aminoethoxydiphenyl borate. Reintroduction of TRα improved IP3R1-mediated mitochondrial Ca2+ overload in aged cells. Our findings uncover a novel mechanism by which TRα deficiency induces mitochondrial Ca2+ overload through IP3R1-mediated Ca2+ transfer in MAM, exacerbating skeletal muscle atrophy during ageing. The TRα/IP3R1 pathway in MAM Ca2+ transfer presents a potential therapeutic target for sarcopenia.
| [1] |
B. Kirk, P. M. Cawthon, H. Arai, et al., “The Conceptual Definition of Sarcopenia: Delphi Consensus From the Global Leadership Initiative in Sarcopenia (GLIS),” Age and Ageing 53, no. 3 (2024): afae052.
|
| [2] |
H. Nishikawa, S. Fukunishi, A. Asai, K. Yokohama, S. Nishiguchi, and K. Higuchi, “Pathophysiology and Mechanisms of Primary Sarcopenia (Review),” International Journal of Molecular Medicine 48, no. 2 (2021): 156.
|
| [3] |
D. A. Hood, J. M. Memme, A. N. Oliveira, and M. Triolo, “Maintenance of Skeletal Muscle Mitochondria in Health, Exercise, and Aging,” Annual Review of Physiology 81 (2019): 19–41.
|
| [4] |
R. Bravo-Sagua, V. Parra, C. López-Crisosto, et al., “Calcium Transport and Signaling in Mitochondria,” Comprehensive Physiology 7, no. 2 (2017): 623–634.
|
| [5] |
J. Zhou, K. Dhakal, and J. Yi, “Mitochondrial Ca(2+) Uptake in Skeletal Muscle Health and Disease,” Science China. Life Sciences 59, no. 8 (2016): 770–776.
|
| [6] |
L. L. Walkon, J. O. Strubbe-Rivera, and J. N. Bazil, “Calcium Overload and Mitochondrial Metabolism,” Biomolecules 12, no. 12 (2022): 1891.
|
| [7] |
C. T. Madreiter-Sokolowski, C. Thomas, and M. Ristow, “Interrelation Between ROS and Ca(2+) in Aging and Age-Related Diseases,” Redox Biology 36 (2020): 101678.
|
| [8] |
A. Yadav and R. Dabur, “Skeletal Muscle Atrophy After Sciatic Nerve Damage: Mechanistic Insights,” European Journal of Pharmacology 970 (2024): 176506.
|
| [9] |
S. M. Korotkov, “Mitochondrial Oxidative Stress Is the General Reason for Apoptosis Induced by Different-Valence Heavy Metals in Cells and Mitochondria,” International Journal of Molecular Sciences 24, no. 19 (2023): 14459.
|
| [10] |
N. Cheema, A. Herbst, D. Mckenzie, and J. M. Aiken, “Apoptosis and Necrosis Mediate Skeletal Muscle Fiber Loss in Age-Induced Mitochondrial Enzymatic Abnormalities,” Aging Cell 14, no. 6 (2015): 1085–1093.
|
| [11] |
N. Rajabian, A. Shahini, M. Asmani, et al., “Bioengineered Skeletal Muscle as a Model of Muscle Aging and Regeneration,” Tissue Engineering, Part A 27, no. 1–2 (2021): 74–86.
|
| [12] |
J. F. Garbincius and J. W. Elrod, “Mitochondrial Calcium Exchange in Physiology and Disease,” Physiological Reviews 102, no. 2 (2022): 893–992.
|
| [13] |
S. Marchi, S. Patergnani, S. Missiroli, et al., “Mitochondrial and Endoplasmic Reticulum Calcium Homeostasis and Cell Death,” Cell Calcium 69 (2018): 62–72.
|
| [14] |
A. Gil-Hernández and A. Silva-Palacios, “Relevance of Endoplasmic Reticulum and Mitochondria Interactions in Age-Associated Diseases,” Ageing Research Reviews 64 (2020): 101193.
|
| [15] |
Y. H. Jung, C. W. Chae, G. E. Choi, et al., “Cyanidin 3-O-Arabinoside Suppresses DHT-Induced Dermal Papilla Cell Senescence by Modulating p38-Dependent ER-Mitochondria Contacts,” Journal of Biomedical Science 29, no. 1 (2022): 17.
|
| [16] |
L. Ji, X. Zhang, Z. Chen, et al., “High Glucose-Induced p66Shc Mitochondrial Translocation Regulates Autophagy Initiation and Autophagosome Formation in Syncytiotrophoblast and Extravillous Trophoblast,” Cell Communication and Signaling 22, no. 1 (2024): 234.
|
| [17] |
S. S. Zhang, S. Zhou, Z. J. Crowley-Mchattan, R. Y. Wang, and J. P. Li, “A Review of the Role of Endo/Sarcoplasmic Reticulum-Mitochondria Ca(2+) Transport in Diseases and Skeletal Muscle Function,” International Journal of Environmental Research and Public Health 18, no. 8 (2021): 3874.
|
| [18] |
P. Atakpa-Adaji and A. Ivanova, “IP(3)R at ER-Mitochondrial Contact Sites: Beyond the IP(3)R-GRP75-VDAC1 ca(2+) Funnel,” Contact (Thousand Oaks) 6 (2023): 25152564231181020.
|
| [19] |
S. Dong, Y. Wu, Y. Zhang, et al., “IP3R-1 Aggravates Endotoxin-Induced Acute Lung Injury in Mice by Regulating MAM Formation and Mitochondrial Function,” Experimental Biology and Medicine (Maywood, N.J.) 248, no. 23 (2023): 2262–2272.
|
| [20] |
D. V. Ziegler, D. Vindrieux, D. Goehrig, et al., “Calcium Channel ITPR2 and Mitochondria-ER Contacts Promote Cellular Senescence and Aging,” Nature Communications 12, no. 1 (2021): 720.
|
| [21] |
W. Chen, Z. Shen, W. Dong, et al., “Polygonatum Sibiricum PolySaccharide Ameliorates Skeletal Muscle Aging via Mitochondria-Associated Membrane-Mediated Calcium Homeostasis Regulation,” Phytomedicine 129 (2024): 155567.
|
| [22] |
J. Chen, L. Wei, X. Zhu, et al., “TT3, a More Practical Indicator for Evaluating the Relationship Between Sarcopenia and Thyroid Hormone in the Euthyroid Elderly Compared With FT3,” Clinical Interventions in Aging 18 (2023): 1285–1293.
|
| [23] |
Y. Sheng, D. Ma, Q. Zhou, et al., “Association of Thyroid Function With Sarcopenia in Elderly Chinese Euthyroid Subjects,” Aging Clinical and Experimental Research 31, no. 8 (2019): 1113–1120.
|
| [24] |
J. Brtko, “Thyroid Hormone and Thyroid Hormone Nuclear Receptors: History and Present State of Art,” Endocrine Regulations 55, no. 2 (2021): 103–119.
|
| [25] |
A. Milanesi, J. W. Lee, N. H. Kim, et al., “Thyroid Hormone Receptor α Plays an Essential Role in Male Skeletal Muscle Myoblast Proliferation, Differentiation, and Response to Injury,” Endocrinology 157, no. 1 (2016): 4–15.
|
| [26] |
Y. Sheng, X. Zhu, L. Wei, et al., “Aberrant Expression of Thyroidal Hormone Receptor α Exasperating Mitochondrial Dysfunction Induced Sarcopenia in Aged Mice,” Aging (Albany NY) 16, no. 8 (2024): 7141–7152.
|
| [27] |
J. Charan and N. D. Kantharia, “How to Calculate Sample Size in Animal Studies?,” Journal of Pharmacology and Pharmacotherapeutics 4, no. 4 (2013): 303–306.
|
| [28] |
Y. Ono, M. Saito, K. Sakamoto, et al., “C188-9, a Specific Inhibitor of STAT3 Signaling, Prevents Thermal Burn-Induced Skeletal Muscle Wasting in Mice,” Frontiers in Pharmacology 13 (2022): 1031906.
|
| [29] |
M. Giacomello and L. Pellegrini, “The Coming of Age of the Mitochondria-ER Contact: A Matter of Thickness,” Cell Death and Differentiation 23, no. 9 (2016): 1417–1427.
|
| [30] |
R. Shi, G. Chen, Y. Zhang, et al., “RNA-Seq and ChIP-Seq Unveils Thyroid Hormone Receptor α Deficiency Affects Skeletal Muscle Myoblast Proliferation and Differentiation via Col6a1 During Aging,” Journal of Muscle Research and Cell Motility (2025).
|
| [31] |
W. S. Dantas, E. R. M. Zunica, E. C. Heintz, et al., “Mitochondrial Uncoupling Attenuates Sarcopenic Obesity by Enhancing Skeletal Muscle Mitophagy and Quality Control,” Journal of Cachexia, Sarcopenia and Muscle 13, no. 3 (2022): 1821–1836.
|
| [32] |
L. Grevendonk, N. J. Connell, C. Mccrum, et al., “Impact of Aging and Exercise on Skeletal Muscle Mitochondrial Capacity, Energy Metabolism, and Physical Function,” Nature Communications 12, no. 1 (2021): 4773.
|
| [33] |
H. L. Glover, A. Schreiner, G. Dewson, and S. W. G. Tait, “Mitochondria and Cell Death,” Nature Cell Biology 26, no. 9 (2024): 1434–1446.
|
| [34] |
D. Salvatore, W. S. Simonides, M. Dentice, A. M. Zavacki, and P. R. Larsen, “Thyroid Hormones and Skeletal Muscle–New Insights and Potential Implications,” Nature Reviews Endocrinology 10, no. 4 (2014): 206–214.
|
| [35] |
L. Wang, Y. Sheng, W. Xu, et al., “Mechanism of Thyroid Hormone Signaling in Skeletal Muscle of Aging Mice,” Endocrine 72, no. 1 (2021): 132–139.
|
| [36] |
L. Boyman, M. Karbowski, and W. J. Lederer, “Regulation of Mitochondrial ATP Production: Ca(2+) Signaling and Quality Control,” Trends in Molecular Medicine 26, no. 1 (2020): 21–39.
|
| [37] |
Y. F. Yang, W. Yang, Z. Y. Liao, et al., “MICU3 Regulates Mitochondrial Ca(2+)-Dependent Antioxidant Response in Skeletal Muscle Aging,” Cell Death & Disease 12, no. 12 (2021): 1115.
|
| [38] |
J. Nehme, L. Mesilmany, M. Varela-Eirin, et al., “Converting Cell Death Into Senescence by PARP1 Inhibition Improves Recovery From Acute Oxidative Injury,” Nature Aging 4, no. 6 (2024): 771–782.
|
| [39] |
S. Sudevan, M. Takiura, Y. Kubota, et al., “Mitochondrial Dysfunction Causes Ca(2+) Overload and ECM Degradation-Mediated Muscle Damage in C. elegans,” FASEB Journal 33, no. 8 (2019): 9540–9550.
|
| [40] |
C. T. Madreiter-Sokolowski, M. Waldeck-Weiermair, M. P. Bourguignon, et al., “Enhanced Inter-Compartmental ca(2+) Flux Modulates Mitochondrial Metabolism and Apoptotic Threshold During Aging,” Redox Biology 20 (2019): 458–466.
|
| [41] |
J. Janikiewicz, J. Szymański, D. Malinska, et al., “Mitochondria-Associated Membranes in Aging and Senescence: Structure, Function, and Dynamics,” Cell Death & Disease 9, no. 3 (2018): 332.
|
| [42] |
F. Vallese, L. Barazzuol, L. Maso, M. Brini, and T. Calì, ER-Mitochondria Calcium Transfer, Organelle Contacts and Neurodegenerative Diseases, vol. 1131 (Advances in Experimental Medicine and Biology, 2020), 719–746.
|
| [43] |
I. Serysheva, “Toward a High-Resolution Structure of IP3R Channel,” Cell Calcium 56, no. 3 (2014): 125–132.
|
| [44] |
C. Wiel, H. Lallet-Daher, D. Gitenay, et al., “Endoplasmic Reticulum Calcium Release Through ITPR2 Channels Leads to Mitochondrial Calcium Accumulation and Senescence,” Nature Communications 5 (2014): 3792.
|
| [45] |
J. Zhou, K. Gauthier, J. P. Ho, et al., “Thyroid Hormone Receptor α Regulates Autophagy, Mitochondrial Biogenesis, and Fatty Acid Use in Skeletal Muscle,” Endocrinology 162, no. 8 (2021): bqab112.
|
| [46] |
X. He, Y. Li, B. Deng, et al., “The PI3K/AKT Signalling Pathway in Inflammation, Cell Death and Glial Scar Formation After Traumatic Spinal Cord Injury: Mechanisms and Therapeutic Opportunities,” Cell Proliferation 55, no. 9 (2022): e13275.
|
| [47] |
D. Wilson, T. Jackson, E. Sapey, and J. M. Lord, “Frailty and Sarcopenia: The Potential Role of an Aged Immune System,” Ageing Research Reviews 36 (2017): 1–10.
|
| [48] |
S. Chen, M. Bie, X. Wang, et al., “PGRN Exacerbates the Progression of Non-Small Cell Lung Cancer via PI3K/AKT/Bcl-2 Antiapoptotic Signaling,” Genes & Diseases 9, no. 6 (2022): 1650–1661.
|
| [49] |
H. Urushima, T. Matsubara, M. Miyakoshi, et al., “Hypo-Osmolarity Induces Apoptosis Resistance via TRPV2-Mediated AKT-Bcl-2 Pathway,” American Journal of Physiology. Gastrointestinal and Liver Physiology 324, no. 3 (2023): G219–g230.
|
| [50] |
N. T. Kamarulzaman and S. Makpol, “The Link Between Mitochondria and Sarcopenia,” Journal of Physiology and Biochemistry 81, no. 1 (2025): 1–20.
|
| [51] |
L. Li, Y. Song, Y. Shi, and L. Sun, “Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges,” Journal of Clinical Endocrinology and Metabolism 108, no. 7 (2023): 1602–1613.
|
| [52] |
R. Zucchi, “Thyroid Hormone Analogues: An Update,” Thyroid 30, no. 8 (2020): 1099–1105.
|
RIGHTS & PERMISSIONS
2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.
PDF
(3035KB)
